ENTITY

Anebulo Pharmaceuticals (ANEB US)

2
Analysis
Health CareUnited States
Anebulo Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing disruptive treatments for substance use disorders, such as cannabinoid overdose and the broader addiction landscape. Anebulo Pharmaceuticals serves customers in the United States.
more
Company Event13 Feb 2026 13:00 • Upcoming
Add To Calendar
Company Event13 Nov 2025 13:00 • Upcoming
Add To Calendar
Company Event30 Sep 2025 04:00 • Upcoming
Add To Calendar
Company Event23 Sep 2025 04:00 • Upcoming
Add To Calendar
Company Event14 May 2025 04:00 • Upcoming
Add To Calendar
x